New Key Statistics Module, Z-Score and F-Score
OTCPK:CLALF Key Ratios
| Market Cap $ M | 21.96 |
| Enterprise Value $ M | 21.88 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.89 |
| Price/Sales | 340.00 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -- |
| Beneish M-Score | -2.88 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -66.30 |
| EV-to-EBIT | 2.26 |
| EV-to-EBITDA | 2.24 |
| PEG | -- |
| Shares Outstanding M | 156.85 |
| Net Margin (%) | -233,553.13 |
| Operating Margin % | -25,396.88 |
| Pre-tax Margin (%) | 112,106.25 |
| Quick Ratio | 2.18 |
| Current Ratio | 2.18 |
| ROA % (ttm) | -48.67 |
| ROE % (ttm) | -76.36 |
| ROIC % (ttm) | -5.65 |
| Dividend Yield % | -- |
| Altman Z-Score | -9.11 |
CLALF Number of Guru Trades
CLALF Volume of Guru Trades
Gurus Latest Trades with OTCPK:CLALF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:CLALF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Clal Biotechnology Industries Ltd Insider Transactions
No Available Data
News about OTCPK:CLALF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers